Skip to main content
. 2021 Nov 17;13(620):eabj7211. doi: 10.1126/scitranslmed.abj7211

Table 1. Details of participants included in this analysis.

Patients all ages Patients aged 18
to 55 		Patients aged 56
to 69 		Patients aged ≥70 Patients with
paired samples
(day 0 and day 28
after dose 2)
ICS flow MenACWY 26 9 7 10 26
AZD1222 57 20 17 20 55
Total 83 29 24 30 81
TCRseq MenACWY 26 18 2 6 14
AZD1222 207 130 26 51 114
Total 233 148 28 57 128